PriMera Scientific Surgical Research and Practice (ISSN: 2836-0028)

Case Study

Volume 4 Issue 3

Fibromyalgia, Anxiety, and Depression and Related Disorders - White Paper

Christina Rahm*

August 16, 2024

DOI : 10.56831/PSSRP-04-128

View PDF

Abstract

Fibromyalgia is a complex condition that can be challenging to diagnose and treat. In addition to the symptoms you mentioned, some people with Fibromyalgia may also experience depression, anxiety, and other mood disorders. Currently, Fibromyalgia cannot be cured, however, various treatments can be found that focus on managing the symptoms and improving quality of life. These may include medications, physical therapy, cognitive behavioral therapy, and lifestyle changes such as exercise, stress management, and good sleep habits. Developing individualized treatment initiative that addresses the specific goals and needs of people with Fibromyalgia, they should work closely with their healthcare provider.

References

  1. Bäckryd E., et al. “Evidence of systemic inflammation and neuroinflammation in fibromyalgia patients, as assessed by a multiplex protein panel applied to the cerebrospinal fluid and plasma”. Journal of Pain Research 9 (2016): 1-13.
  2. Barke A., et al. “Central nervous system mechanisms of Fibromyalgia and widespread chronic pain”. Scandinavian Journal of Pain 4.1 (2013): 1-7.
  3. Blier P, Gobbi G and Turcotte J-E. “Fibromyalgia, depression, and antidepressants”. Journal of Clinical Psychiatry 75.8 (2014): e736-e742.
  4. Clauw DJ. “Fibromyalgia: A clinical review”. Journal of the American Medical Association 313.15 (2015): 1547-1555.
  5. Clauw DJ and Häuser W. “Fibromyalgia and related conditions”. Mayo Clinic Proceedings 89.5 (2014): 728-738.
  6. Cohen H, Neumann L and Shore M. “The relationship between Fibromyalgia and major depressive disorder”. International Journal of Psychiatry in Clinical Practice 4.2 (2000): 15-21.
  7. Crofford LJ. “Adverse effects of chronic opioid therapy for chronic musculoskeletal pain”. Nature Reviews Rheumatology 11.5 (2015): 26-334.
  8. D'Ambrosio F., et al. “The role of anxiety in fibromyalgia syndrome”. Current Rheumatology Reviews 11.2 (2015): 109-115.
  9. Derry S, Moore RA and Gaskell H. “Topical NSAIDs for acute musculoskeletal pain in adults”. Cochrane Database of Systematic Reviews 2014.9 (2014): CD007402.
  10. Derry S., et al. “Topical lidocaine for neuropathic pain in adults”. Cochrane Database of Systematic Reviews 2015.7 (2015): CD010958.
  11. Fitzcharles M-A and Yunus MB. “Fibromyalgia's clinical concept has changed in the past 20 years”. Pain Research and Treatment (2012): 1-7.
  12. Hauser W, Bernardy K and Uçeyler N. “Treatment of fibromyalgia syndrome with gabapentin and pregabalin—A meta-analysis of randomized controlled trials”. Pain 154.10 (2013): 1799-1806.
  13. Hauser W., et al. “Postinfectious and chronic fatigue syndromes: Clinical experience from a specialized center for treating CFS/ME”. Der Nervenarzt 88.6 (2017): 624-633.
  14. Hauser W, Petzke F and Sommer C. “Comparative efficacy and acceptability of amitriptyline, duloxetine and milnacipran in fibromyalgia syndrome: A systematic review with meta-analysis”. Rheumatology 49.4 (2010): 716-726.
  15. Hauser W., et al. “Guidelines on the management of fibromyalgia syndrome - A systematic review”. European Journal of Pain 18.2 (2014): 111-140.
  16. Hauser W and Wolfe F. “Diagnosis and diagnostic tests for Fibromyalgia (syndrome)”. Rheumatic Diseases Clinics of North America 41.2 (2015): 319-333.
  17. Hewlett S., et al. “Self-management of fatigue in rheumatoid arthritis: A randomized controlled trial of group cognitive-behavioral therapy”. Annals of the Rheumatic Diseases 70.6 (2011): 1060-1067.
  18. Hudson JI and Goldenberg DL. “Psychological aspects of Fibromyalgia”. Current Opinion in Rheumatology 1.2 (1986): 192-197.
  19. Lachaine J., et al. “An economic evaluation of duloxetine in patients with Fibromyalgia”. Current Medical Research and Opinion 31.1 (2015): 97-109.
  20. Hauser W, Bialas P and Welsch K. “Psychiatric comorbidity in patients with fibromyalgia syndrome: A selective literature review”. Journal of Psychosomatic Research 79.2 (2015): 135-147.
  21. Hauser W and Fitzcharles M-A. “Facts and myths pertaining to Fibromyalgia”. Dialogues in Clinical Neuroscience 20.1 (2018): 53-62.
  22. Hauser W, Sarzi-Puttini P and Fitzcharles M-A. “Fibromyalgia syndrome: Under-, over-and misdiagnosis”. Clinical and Experimental Rheumatology 37.Suppl 116 (2019): 90-97.
  23. Hayes SM, Kohler M and Lauzon S. “Understanding the complex interplay between depression, anxiety, and chronic pain in women”. Depression and Anxiety 35.5 (2018): 465-480.
  24. Kashikar-Zuck S., et al. “Depression and functional disability in chronic pediatric pain”. Clinical Journal of Pain 17.4 (2001): 341-349.
  25. Lai C-H. “Major depressive disorder: Gender differences in symptoms, life quality, and sexual function”. Journal of Clinical Psychopharmacology 35.6 (2015): 608-616.
  26. Mannerkorpi K, Nordeman L and Cider Å. “Fibromyalgia: An update on treatment options with a focus on pharmacological approaches”. Current Opinion in Rheumatology 29.3 (2017): 167-173.
  27. Martinez-Lavin M. “Biology and therapy of Fibromyalgia: Stress, the stress response system, and Fibromyalgia”. Arthritis Research & Therapy 21.1 (2019): 1-10.
  28. Morasco BJ., et al. “The relationship between PTSD and chronic pain: Mediating role of coping strategies and depression”. Pain 154.4 (2013): 609-616.
  29. O'Brien CP. “Addiction and dependence in DSM-V”. Addiction 108.5 (2013): 866-867.
  30. Perrot S., et al. “The fibromyalgia syndrome”. Handbook of Clinical Neurology 145 (2017): 375-401.
  31. Rizzi M., et al. “A systematic review and meta-analysis of usual treatment versus psychosocial interventions in Fibromyalgia”. Journal of Psychosomatic Research 126 (2019): 109796.
  32. Salaffi F., et al. “The relationship between Fibromyalgia and major depressive disorder: A comprehensive review”. Current Psychiatry Reviews 16.4 (2020): 54-273.
  33. Schiepers OJG, Wichers MC and Maes M. “Cytokines and major depression”. Progress in Neuro-Psychopharmacology and Biological Psychiatry 29.2 (2005): 201-217.
  34. Thieme K., et al. “Psychological interventions for chronic pain: A review of current evidence”. Current Opinion in Supportive and Palliative Care 12.2 (2018): 163-168.
  35. Turk DC, Wilson HD and Cahana A. “Treatment of chronic pain: Patients with Fibromyalgia”. Journal of the American Medical Association 306.6 (2011): 590-598.
  36. Wolfe F., et al. “Two thousand sixteen revisions to the 2010/2011 fibromyalgia diagnostic criteria”. Seminars in Arthritis and Rheumatism 46.3 (2016): 19-329.
  37. Yunus MB. “Fibromyalgia and overlapping disorders: The unifying concept of central sensitivity syndromes”. Seminars in Arthritis and Rheumatism 44.5 (2015): 595-596.